These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26298570)

  • 1. Mortality and metformin use in patients with advanced chronic kidney disease.
    Lalau JD; Kajbaf F; Arnouts P; de Broe M
    Lancet Diabetes Endocrinol; 2015 Sep; 3(9):680-1. PubMed ID: 26298570
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic kidney disease: Metformin increases risk of mortality in patients with advanced chronic kidney disease.
    Edwards JK
    Nat Rev Nephrol; 2015 Aug; 11(8):443. PubMed ID: 26149836
    [No Abstract]   [Full Text] [Related]  

  • 3. Mortality and metformin use in patients with advanced chronic kidney disease--Authors' reply.
    Hung SC; Chang YK; Liu JS; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Sep; 3(9):681. PubMed ID: 26298571
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapy: Risk of metformin use in patients with T2DM and advanced CKD.
    Schernthaner G; Schernthaner-Reiter MH
    Nat Rev Endocrinol; 2015 Dec; 11(12):697-9. PubMed ID: 26284445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in chronic kidney disease: more harm than help?
    Kalantar-Zadeh K; Rhee CM
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):579-81. PubMed ID: 26094106
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic kidney diseases, metformin and lactic acidosis].
    Borbély Z
    Vnitr Lek; 2016 Apr; 62(4):299-303. PubMed ID: 27250607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?
    Stanton RC
    Am J Kidney Dis; 2015 Aug; 66(2):193-5. PubMed ID: 25960301
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin should not be contraindicated in patients with type 2 diabetes and mild to moderate renal impairment.
    Scheen AJ
    Evid Based Med; 2015 Jun; 20(3):115. PubMed ID: 25827139
    [No Abstract]   [Full Text] [Related]  

  • 10. Restricting Metformin in CKD: Continued Caution Warranted.
    Rhee CM; Kalantar-Zadeh K
    Am J Kidney Dis; 2015 Dec; 66(6):1101-2. PubMed ID: 26593314
    [No Abstract]   [Full Text] [Related]  

  • 11. In Reply to 'Restricting Metformin in CKD: Continued Caution Warranted'.
    Stanton RC
    Am J Kidney Dis; 2015 Dec; 66(6):1102. PubMed ID: 26593315
    [No Abstract]   [Full Text] [Related]  

  • 12. Metformin OK in CKD?
    Drug Ther Bull; 2014 Apr; 52(4):37. PubMed ID: 24698854
    [No Abstract]   [Full Text] [Related]  

  • 13. [Proposal for the modification of metformin use in patients with chronic kidney disease].
    Balogh Z; Mátyus J
    Orv Hetil; 2012 Sep; 153(39):1527-35. PubMed ID: 23000419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity of Metformin and Hypoglycemic Therapies.
    Akhter MS; Uppal P
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):18-30. PubMed ID: 32146997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin use in decompensated heart failure.
    Boyd A; Nawarskas J
    Cardiol Rev; 2008; 16(5):269-72. PubMed ID: 18708828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin and risk of cardiovascular disease.
    Turner RC; Holman RR
    Cardiology; 1999; 91(3):203-4. PubMed ID: 10516415
    [No Abstract]   [Full Text] [Related]  

  • 17. Refining metformin prescribing in New Zealand.
    Jayathissa S; Dixon P; Bruce R; Reith D
    N Z Med J; 2017 Mar; 130(1452):49-53. PubMed ID: 28337040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Don't throw the baby out with the bath water: mortality with combination metformin and sulfonylurea.
    Tayek JA
    Diabetes Metab Res Rev; 2007 Feb; 23(2):85-6. PubMed ID: 17262894
    [No Abstract]   [Full Text] [Related]  

  • 19. Metformin-associated mortality in U.S. studies.
    Innerfield RJ
    N Engl J Med; 1996 Jun; 334(24):1611-2; author reply 1612-3. PubMed ID: 8628355
    [No Abstract]   [Full Text] [Related]  

  • 20. Metformin therapy in patients with chronic kidney disease.
    Duong JK; Roberts DM; Furlong TJ; Kumar SS; Greenfield JR; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Diabetes Obes Metab; 2012 Oct; 14(10):963-5. PubMed ID: 22564555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.